Dobryszycka W, Warwas M, Gerber J, Ujec M
Neoplasma. 1979;26(6):737-43.
The following enzymatic activities were measured in serum of patients with benign and malignant ovarian tumors before treatment: alkaline and acid phosphatases, aspartyl (AspAT) and alanyl (AlAT) aminotransferases, leucyl (LAP) and alanyl (AAP) aminopeptidases, lactate dehydrogenase (LDH), gamma-glutamyl transpeptidase, cathepsin, alkaline ribonuclease (RNase) and beta-glucuronidase. It was shown that at least three determinations (phosphatases and LAP) are practically useless in a discrimination between the examined groups. RNase in combination with AspAT (AlAT) or RNase with AAP and LDH were found to give the best results as marker enzymes.
碱性磷酸酶和酸性磷酸酶、天冬氨酸氨基转移酶（AspAT）和丙氨酸氨基转移酶（AlAT）、亮氨酰氨基肽酶（LAP）和丙氨酰氨基肽酶（AAP）、乳酸脱氢酶（LDH）、γ-谷氨酰转肽酶、组织蛋白酶、碱性核糖核酸酶（RNase）和β-葡萄糖醛酸酶。结果表明，至少三项检测（磷酸酶和LAP）在区分所检查的组时实际上没有用处。发现RNase与AspAT（AlAT）联合使用，或RNase与AAP和LDH联合使用作为标记酶可产生最佳结果。
